Key Takeaway: Brian Nguyen holds a B.S. in Biochemistry from UCLA and has extensive experience in laboratory settings. He started as a lab assistant at UC San Diego, later becoming a lab manager. His career progressed into the industry, focusing on high-throughput screening drug discovery, and he joined Immuneering in 2022.
Price reaction · baseline $6.73 (2025-12-26 close) · 25 other IMRX headline(s) in the window, move may be shared
day 0 close · peak
-1%
Market Sentiment Analysis
POSITIVE FACTORS
Brian Nguyen has a strong educational background in Biochemistry.
He has gained valuable experience in both academic and industry settings.
His transition to Immuneering reflects career advancement.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+41%
120-day peak, hindsight
Typical move
11.4%
average across 8 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
IMM-1-104 Monotherapy
Phase 1 · Advanced Solid Tumor
Full Press Release Details
Brian Nguyen earned his B.S. in Biochemistry from the University of California, Los Angeles. He began working as a lab assistant at the University of California, San Diego and eventually became a lab manager. He transitioned to industry working in a high-throughput screening drug discovery program. In 2022, he joined Immuneering.
Frequently Asked Questions
What degree does Brian Nguyen hold?
Brian Nguyen earned a B.S. in Biochemistry from UCLA.
Where did Brian Nguyen work before Immuneering?
He worked as a lab assistant and manager at UC San Diego.
What was Brian Nguyen's focus in the industry?
He focused on high-throughput screening drug discovery.